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Abstract
Background: The clinical outcomes for left anterior descending (LAD) coronary artery lesion between minimally
invasive direct coronary artery bypass (MIDCAB) and percutaneous coronary intervention (PCI) are still controversial.
The objective was to compare safety and efficacy between MIDCAB and PCI for LAD.
Methods: Electronic databases and article references were systematically searched to access relevant studies. End
points included mortality, myocardial infarction, target vessel revascularization (TVR), major adverse coronary events
(MACE), angina recurrence, and stroke.
Results: Fourteen studies with 941 patients were finally involved in the present study. The mortality and incidence
of myocardial infarction were similar in MIDCAB and PCI groups at 30 days, 6 months, and at follow-up beyond
1 year. Compared with PCI, MIDCAB decreased incidence of TVR and MACE at 6 months and beyond 1 year follow-up.
MIDCAB was associated with a lower incidence of angina recurrence at 6 months compared with PCI. PCI was
associated with higher risk of restenosis in target vessel. No significant difference was shown for stroke.
Conclusion: Our meta-analysis indicates that there are no significant differences in the safety between MIDCAB and
PCI in patients with LAD. However MIDCAB is superior to PCI for TVR and MACE.
Keywords: Left anterior descending coronary artery, Minimally invasive direct coronary artery bypass, Percutaneous
coronary intervention, Outcome
Background
Minimally invasive direct coronary artery bypass (MID-
CAB) and percutaneous coronary intervention (PCI) are
alternative procedures to mechanical revascularization
for patients with left anterior descending (LAD) coron-
ary artery lesion. The effects of these two procedures on
cardiovascular outcomes have been compared in several
clinical trials. Further, the comparative effectiveness of
MIDCAB and PCI remains poorly understood for pa-
tients in whom both procedures are technically feasible
and coronary revascularization is clinically indicated.
Since the publication of those meta-analyses, additional
trials and long term results have become available Meta-
analyses of individual patient data from clinical con-
trolled trials substantially have the potential to increase
the power and improve the precision of treatment effects
and safety. Thus, the goal of this study was to perform a
meta-analysis of trials to evaluate the comparative effect-
iveness of MIDCAB and PCI among patients with iso-
lated lesions of the LAD.
Methods
Search strategy and selection criteria
Two investigators (WX and QC) independently searched
the literatures collected in PubMed, MEDLINE,
EMBASE, Science Direct, ISI Web of Knowledge, and
Cochrane databases up to August 1, 2015. Search terms
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included: percutaneous coronary intervention, stent,
minimally invasive coronary artery bypass, MIDCAB,
off-pump coronary surgery, left anterior descending, and
clinical trial. We also sought additional studies by
reviewing the reference lists of included articles, confer-
ence abstracts, and the bibliographies of expert advisors.
The searches were limited to English publications in
humans. We did not include abstracts or meeting pro-
ceedings. This search strategy was performed iteratively
until no new potential citations could be found on re-
view of the reference lists of retrieved articles.
Studies were included if they met all of the follow-
ing criteria: (1) studies comparing MIDCAB with PCI
for the treatment of isolated lesions of LAD; (2)
reporting at least one pertinent clinical outcome. Ex-
clusion criteria included: (1) duplicate publication, (2)
ongoing/unpublished study, (3) studies published only
as an abstract or in conference proceedings. Hybrid
and robotically assisted surgery studies were excluded.
In addition, if the same author published multiple
studies reporting outcomes at different follow-up
points, we extracted patient characteristics from the
first study, with data for outcomes of interest at sub-
sequent follow-up times extracted from the later
studies. When two studies by the same institution re-
ported the same out comes at similar follow-up pe-
riods, we included in our analysis either the better
quality or the most informative publication.
Data extraction
The quality of the studies was assessed by using the
Newcastle Ottawa Scale system, in particular the use of
stars awarded for each numbered criterion item. Two of
us (WX and QC) evaluated the quality of all included
studies by examining three items: patient selection, com-
parability of MIDCAB and PCI groups, and assessment
of outcomes.
All data were extracted from article texts, tables,
and figures. Two individual investigators (WX and
QC) independently extracted data on patient and
study characteristics, outcomes, and study quality for
each trial using a standardized protocol and reporting
form. Disagreements were resolved by consensus with
a third reviewer (LZ).
Study outcomes and definitions
The end points of this meta-analysis were as follow: (1)
mortality; (2) major adverse coronary events (MACE);
(3) target vessel revascularization (TVR); (4) myocardial
infarction (MI); (5) angina recurrence; (6) restenosis; (7)
stroke. Death was defined as death from any cause. The
original study authors’ definition of MACE was used and
usually included the composite of death, myocardial in-
farction, and cerebrovascular accident or stroke. TVR
was defined as repeat PCI of the treated vessel including
any segment of the left anterior descending and/or left
circumflex coronary artery. MI included Q-wave MI and
non-Q-wave MI. Agina recurrence and restenosis were
defined according to study authors’ definitions. Stroke
was defined as a sudden neurologic deficit resulting
from vascular lesions of the brain including hemorrhage,
embolism, or thrombosis.
Statistical methods
We used fixed-effects or random-effects models to pro-
duce across-study summary relative risk (RR) with 95 %
confidence interval (CI). The pooled effects were calcu-
lated using fixed-effect model with the Mantel-Haenszel
Fig. 1 Flow diagram of studies included in the final meta-analysis
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Table 1 Summary of baseline patient characteristics from comparative studies included in the present meta-analysis
No. of patients Age (years) Male (%) Hypertension (%) Diabetes (%) Previous cerebrovascularevent
Author PCI MIDCAB PCI MIDCAB PCI MIDCAB PCI MIDCAB PCI MIDCAB PCI MIDCAB
Cisowski [1–3] 50 50 53.3 ± 10.2 54.1 ± 9.1 42 41 26 (52 %) 28 (56 %) 4 (8 %) 3 (6 %) NR NR
Drenth [3, 5–7] 51 51 61 (1.3) 60 (1.6) 75 78 33 16 18 24 NR NR
Diegeler [8–10] 110 110 62.5 ± 10.2 61.6 ± 10.0 72 77 72 71 34 25 NR NR
Reeves [11] 50 50 54.5 (49-61) 58.8 (53–67) 86 70 NR NR NR NR NR NR
Hong [12] 119 70 60.5 ± 9.6 61.4 ± 9.9 63.9 64.3 50.4 55.7 37 48.6 2.5 2.9
Kim [13] 50 50 61 ± 12 63 ± 12 60 70 55 55 20 15 2 2
Thiele [14] 65 65 66 (59–72) 66 (59–71) 69 71 83 85 28 25 3 9
Previous MI (%) Smokers (%) Hypercholesterolaemia (%) Ejection fraction (%) Unstable angina (%) Family history of coronary
PCI MIDCAB PCI MIDCAB PCI MIDCAB PCI MIDCAB PCI MIDCAB PCI MIDCAB
Cisowski [1–3] NR NR 26 (52 %) 24 (48 %) 39 (78 %) 38 (76 %) NR NR 5 (10 %) 4 (8 %) 20 (40 %) 22 (44 %)
Drenth [3, 5–7] 18 24 30 37 45 41 NR NR NR NR 50 46
Diegeler [8–10] 45 45 25 25 70 73 62 ± 15 63 ± 11 NR NR 18 17
Reeves [11] NR NR NR NR NR NR NR NR NR NR NR NR
Hong [12] 21.8 22.9 40.3 45.7 54.6 51.4 52.8 ± 8.8 51.9 ± 9.1 50.4 42.9 9.3 10
Kim [13] 22 22 45 55 60 70 51 ± 11 49 ± 13 65 55 NR NR












method when there was no significant heterogeneity or
with DerSimonian–Laird weights for the random effects
model when there was significant heterogeneity. The
chi-square test was used to study heterogeneity between
trials, and the I2 statistic was used to estimate the per-
centage of total variation across studies. I2 value greater
than 50 % was considered as significant heterogeneity.
Sensitivity analyses were performed to compare the
treatment effects obtained from different subgroups with
the overall treatment effects. Publication bias was ex-
plored through visual inspection of funnel plots and
assessed by applying the Egger weighted regression
statistic with a p value < 0.05 indicating significant
publication bias among the included studies. Correc-
tion for publication bias was performed using trim-
and-fill methods. A p value < 0.05 was regarded as
significant. All statistical analyses were performed
using Review Manager (version 5, Cochrane Collaboration,
Oxford, UK).
Results
Characteristics of included studies
The literature search identified 308 relative references.
After selection according to the inclusion/exclusion cri-
teria, 14 studies were eligible for meta-analysis finally
(Fig. 1). A total of 941 patients were involved, of whom
495 patients undergoing PCI and 446 patients undergo-
ing MIDCAB, as summarized in Table 1 [1–14]. Two
groups each published three studies reporting on the
same patient group but were included due to they re-
ported outcomes at different follow-up periods in each
of these studies.
Fig. 2 Comparison of PCI versus MIDCAB for the outcome of mortality at 30 days, 6 months, and beyond 1 year follow-up. PCI, percutaneous
coronary intervention; MIDCAB, minimally invasive direct coronary artery bypass
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Assessment of mortality
As shown in Fig. 2, at 30 days follow-up, PCI and MID-
CAB were not different in risk of mortality (0.5 % vs
1.3 %; RR, 0.39; 95 % confidence interval [CI], 0.09-1.66;
P = 0.20; I2 = 0 %). At 6 months follow-up, the overall
OR of mortality showed no difference between PCI and
MIDCAB (1.2 % vs 1.4 %; OR, 0.86; 95 % CI, 0.25-2.91;
P = 0.81). We found a moderate level of heterogeneity
(I2 = 42 %, p = 0.22) for the pooled results for mortality.
Similarly, at ≥ 1 year follow-up, PCI and MIDCAB were
not different in risk of mortality (8.0 % vs 10.5 %; OR,
0.97; 95 % CI, 0.55-1.73; P = 0.93; I2 = 0 %).
Assessment of myocardial infarction
Myocardial infarction was not significantly different be-
tween PCI and MIDCAB at 30 days (3.0 % vs 2.9 %; OR,
1.03; 95 % CI, 0.49-2.18; P = 0.93; I2 = 18 %), 6 months
(2.8 % vs 3.8 %; OR, 0.77; 95 % CI, 0.34-1.74; P =
0.53), ≥ 1 year (6.3 % vs 6.1 %; OR, 1.03; 95 % CI,
0.57-1.89; P = 0.92). We found a low level of hetero-
geneity (I2 = 39 %, p = 0.18) in the pooled results for
MI at 6 months and moderate level of heterogeneity
(I2 = 57 %, p = 0.04) at ≥ 1 year (Fig. 3).
Assessment of TVR
The incidence of TVR was similar in patients under-
going PCI with PCI versus MIDCAB at 30 days
(1.75 % vs 1.37 %; OR, 1.30; 95 % CI, 0.40-4.17; P =
0.66; I2 = 22 %). However, the TVR was significantly
higher after PCI compared with MIDCAB at 6 months
(12.9 % vs 3.2 %; OR, 5.20; 95 % CI, 2.48-10.92; P <
0.001; I2 = 0 %), ≥ 1 year (17.6 % vs 4.4 %; OR, 4.92;
95 % CI, 2.67-9.08; P <0.00001; I2 = 0 %). These re-
sults are summarized in Fig. 4.
Fig. 3 Comparison of PCI versus MIDCAB for the outcome of MI at 30 days, 6 months, and beyond 1 year follow-up. PCI, percutaneous coronary
intervention; MIDCAB, minimally invasive direct coronary artery bypass
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Assessment of MACE
No significant difference was found between DES and
CABG groups in the risk of MACE at 30 days follow-up
(4.4 % vs 6.3 %; OR, 0.70; 95 % CI, 0.27-1.83; P = 0.89;
I2 = 71 %). MACE, however, occurred significantly more
frequently after PCI than MIDCAB at 6 months (18.2 %
vs 9.3 %; OR, 2.12; 95 % CI, 1.19-3.79; P = 0.0009; I2 =
75 %), and ≥ 1 year (23.4 % vs 15.4 %; OR, 1.84; 95 %
CI, 1.21-2.78; P = 0.004; I2 = 0 %). These results are
summarized in Fig. 5.
Assessment of angina recurrence
Pooled effects showed no significant difference in the in-
cidence of angina recurrence between the PCI group
and the MIDCAB group during the initial 30 days (12 %
vs 2 %; OR, 6.68; 95 % CI, 0.77-57.70; P = 0.08) and over
1 years follow-up (26.5 % vs 23.2 %; OR, 1.16; 95 % CI,
0.80-1.16; P = 0.43; I2 = 48 %). However, at 6 months
follow-up risk for angina recurrence was significantly
lower in the MIDCAB group compared to the PCI group
(28.7 % vs 12.9 %; OR, 2.86; 95 % CI, 1.70-4.81; P <
0.0001). We found a moderate level of heterogeneity
(I2 = 53 %, p = 0.12) for the pooled results for angina
recurrence at 6 months follow-up. These results are
summarized in Fig. 6.
Assessment of stroke
Figure 7 shows the overall OR as well as the ORs of
individual trials regarding stroke. No heterogeneity
across the trials was observed regarding this event (I2 =
0 %, p = 0.57). There was no significant difference in the
risk of stroke between PCI and MIDCAB (1.2 % vs
0.7 %; OR, 1.39; 95 % CI, 0.37-5.20; P = 0.63; Fig. 7).
Assessment of restenosis in target vessel
Figure 2 shows the overall OR as well as the ORs of in-
dividual trials regarding restenosis in target vessel. There
was no heterogeneity across the trials. The analysis indi-
cated the risk of restenosis in target vessel was a signifi-
cantly higher in patients treated with PCI compared
Fig. 4 Comparison of PCI versus MIDCAB for the outcome of TVR at 30 days, 6 months, and beyond 1 year follow-up. PCI, percutaneous coronary
intervention; MIDCAB, minimally invasive direct coronary artery bypass; TVR, target vessel revascularization
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with MIDCAB (19.4 % vs 7.9 %; OR, 3.02; 95 % CI,
1.73-5.27; P = 0.0001; I2 = 0 %; Fig. 8).
Discussion
This meta-analysis of RCT studies involving patients
with single LAD coronary artery disease showed that
risk of mortality and myocardial infarction in patients
who receiving PCI were not significantly different from
those underwent MIDCAB in short-term and long-term
follow-ups. However, TVR occurred more frequently in
patients treated with PCI compared to those treated with
MIDCAB. MACCE occurrence was not different be-
tween PCI and MIDCAB in short-term (30 days); how-
ever, in long-term (≥1 year follow-up), MACCE
occurrence was significantly lower after MIDCAB than
after PCI.
Patients with LAD constitute a challenging treatment
group, often with significant comorbidities that increase
the risk of mortality and healthcare costs. The choice of
the appropriate LAD revascularization technique is usu-
ally guided by the angiographic characteristics of the
stenosis, but also by the respective expertise of the inter-
ventional and surgical teams and preferences of the pa-
tient. Recent technical progresses in DES have reduced
restenosis rates and mortality, repeat revascularization,
and MACE compared with bare metal stents [15]. How-
ever, the selection for the optimal revascularization pro-
cedure remains controversial. In previous meta-analysis
found that MIDCAB is associated with lower rates of re-
currence of angina, MACCE, and need for repeat revas-
cularization than PCI [16, 17].
Recent a 10-year long-term follow-up data of clinical
controlled trials comparisons between PCI and MID-
CAB showed that PCI was associated with a statistically
significant increase in target vessel revascularization rate
[10]. The present meta-analysis, summarizing results
from RCT studies including a large ‘real world’ LAD
population, supports the conclusion that PCI continues
to be associated with a significantly higher risk of TVR
and MACE compared with MIDCAB. Our meta-analysis
findings need to be confirmed in ongoing, multicentric
large clinical trials.
Fig. 5 Comparison of PCI versus MIDCAB for the outcome of MACE at 30 days, 6 months, and beyond 1 year follow-up. PCI, percutaneous
coronary intervention; MIDCAB, minimally invasive direct coronary artery bypass; MACE, major adverse coronary events
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Fig. 6 Comparison of PCI versus MIDCAB for the outcome of angina recurrence at 30 days, 6 months, and beyond 1 year follow-up. PCI, percutaneous
coronary intervention; MIDCAB, minimally invasive direct coronary artery bypass
Fig. 7 Comparison of PCI versus MIDCAB for the outcome of stroke at 30 days, 6 months, and beyond 1 year follow-up. PCI, percutaneous coronary
intervention; MIDCAB, minimally invasive direct coronary artery bypass
Fig. 8 Comparison of PCI versus MIDCAB for the outcome of restenosis in target vessel at 30 days, 6 months, and beyond 1 year follow-up. PCI,
percutaneous coronary intervention; MIDCAB, minimally invasive direct coronary artery bypass
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There are several important limitations in this study.
First, the benefit of PCI or MIDCAB may depend on the
extent and complexity of coronary artery disease. Sec-
ond, some results of our meta-analysis have significant
heterogeneities. Third, definitions of end points were dif-
ferent across included studies. Fourth, we did not have
access to further propensity analysis or stratified analysis
to better define differences between treatment groups.
Fifth, follow-up length for rates of stroke and restenosis
was too short to detect differences between the two
groups. Further, most of the follow-up in this analysis is
up to 1 year. The long-term durability of PCI versus
MIDCAB remains undetermined and will require longer
follow-up. Finally, we would also like to point out the
publication bias exaggerating the positive effects of
MIDCAB when meta-analysis was based on previously
published studies, due to positive results are more ten-
dency to be published than negative results.
Conclusion
In conclusion, MIDCAB reduces the need for TVR, and
incidence of MACE at 6 months and beyond 1 year
when compared with PCI. MIDCAB and PCI were not
significantly different on the mortality, incidence of
myocardial infarction and troke. Overall, current evi-
dence suggests that MIDCAB is still superior to PCI for
the majority of patients with LAD.
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